side effects include:
allergic reactions
azotemia
pancreatitis
coagulopathy
hyperglycemia
cns thrombosis
liver function abnormalities
hyperbilirubinemia
elevated transaminases

hematologic side effects
marked decrease
circulating lymphoblasts
normal leukocyte counts
first days
initiating therapy
marked rise in serum
uric acid
pre-renal azotemia
hypofibrinogenemia
depression of other clotting factors
factors v
marked decreases
factors vii
variable decreases
low incidence of decrease
circulating platelets
bleeding
minority of patients with a demonstrable coagulopathy
intracranial hemorrhage
fatal bleeding
low fibrinogen levels
compensatory increased fibrinolytic activity
transient bone marrow depression
delay in return of hemoglobin
hematocrit levels
patients
undergoing hematologic remission of leukemia
marked leukopenia
hypertriglyceridemia
gastrointestinal side effects
nausea
vomiting
anorexia
acute hemorrhagic pancreatitis
general
side effects
chills
fever
abdominal cramps
weight loss
headache
fatal hyperthermia
most hepatic abnormalities
discontinuation of therapy
reversal
course of therapy
hepatic side effects
elevations of sgot
sgpt
alkaline phosphatase
bilirubin
depression of serum albumin
cholesterol
plasma fibrinogen
increases
total blood lipids
marked hypoalbuminemia
peripheral edema
fatty changes in the liver
biopsy
malabsorption syndrome
nervous system
side effects
discontinuation of asparaginase
nervous system
side effects
somnolence
fatigue
seizures
coma
confusion
parkinson-like syndrome with tremor
progressive increase in muscle tone
cardiovascular
side effects
case of acute myocardial infarction
dermatologic side effects
skin rashes
urticaria
musculoskeletal side effects
arthralgia
respiratory side effects
respiratory distress
metabolic side effects
low incidence of hyperglycemia with glycosuria
polyuria
syndrome
hyperosmolar nonketonic hyperglycemia
syndrome
discontinuation of asparaginase
judicious use
fluid
insulin
psychiatric side effects
depression
agitation
confusion
paranoia
hallucinations
renal side effects
fatal renal insufficiency
proteinuria
serum concentrations of thyroxine-binding globulin
pretreatment values
weeks of the last dose
other side effects
interference with the interpretation of thyroid function tests by production of a rapid
marked reduction in serum concentrations of thyroxine-binding globulin within days after the first dose
oncologic side effects
reports of small increases in pulmonary adenomas in animal studies
.
immunosuppressive activity
animal experiments